MX368125B - Metodos para producir compuestos sulfilimina. - Google Patents
Metodos para producir compuestos sulfilimina.Info
- Publication number
- MX368125B MX368125B MX2014009922A MX2014009922A MX368125B MX 368125 B MX368125 B MX 368125B MX 2014009922 A MX2014009922 A MX 2014009922A MX 2014009922 A MX2014009922 A MX 2014009922A MX 368125 B MX368125 B MX 368125B
- Authority
- MX
- Mexico
- Prior art keywords
- compound
- sulfilimine
- methods
- producing
- sulfide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/57—Nitriles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/32—Sulfur atoms
- C07D213/34—Sulfur atoms to which a second hetero atom is attached
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/06—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
- C07D213/16—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing only one pyridine ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
- C07D275/02—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
- C07D285/08—1,2,4-Thiadiazoles; Hydrogenated 1,2,4-thiadiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
- C07D285/12—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pyridine Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Abstract
Métodos para producir un compuesto sulfilimina, tal como N-ciano-S-metilo-S-[1-(6-trifluorometilo-3-piridinilo)etilo]sulfi limina u otro compuesto sulfilimina sustituido. El método incluye combinar un compuesto sulfido, cianamida, un compuesto de hipoclorito y una base, y oxidizar el compuesto sulfido para formar el compuesto sulfilimina. El compuesto sulfido puede incluir un compuesto 2-trifluorometilo-5-(1-sustituido)alquilo-tio piridina. La base puede incluir hidróxido de sodio. Opcionalmente se puede usar en la reacción, un amortiguador tal como un amortiguador fosfato.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261599489P | 2012-02-16 | 2012-02-16 | |
PCT/US2013/026377 WO2013123349A1 (en) | 2012-02-16 | 2013-02-15 | Methods of producing sulfilimine compounds |
Publications (2)
Publication Number | Publication Date |
---|---|
MX2014009922A MX2014009922A (es) | 2014-11-21 |
MX368125B true MX368125B (es) | 2019-09-19 |
Family
ID=48982761
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2014009922A MX368125B (es) | 2012-02-16 | 2013-02-15 | Metodos para producir compuestos sulfilimina. |
Country Status (19)
Country | Link |
---|---|
US (2) | US9227936B2 (es) |
EP (1) | EP2814812B1 (es) |
JP (1) | JP6138834B2 (es) |
KR (1) | KR102064827B1 (es) |
CN (1) | CN104271555B (es) |
AR (1) | AR090076A1 (es) |
AU (1) | AU2013221420B2 (es) |
BR (1) | BR102013003576B8 (es) |
CA (1) | CA2863994C (es) |
CO (1) | CO7081159A2 (es) |
ES (1) | ES2625106T3 (es) |
IL (1) | IL233956B (es) |
IN (1) | IN2014DN07442A (es) |
MX (1) | MX368125B (es) |
PL (1) | PL2814812T3 (es) |
RU (1) | RU2634718C2 (es) |
UA (1) | UA116628C2 (es) |
WO (1) | WO2013123349A1 (es) |
ZA (1) | ZA201406494B (es) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2013359564A1 (en) * | 2012-12-11 | 2015-06-11 | Dow Agrosciences Llc | Improved process for the preparation of|N-cyano-S-[1 -(pyridin-3-yl)ethyl]-S-methylsulfilimines |
CA2942387A1 (en) | 2014-03-13 | 2015-09-17 | Proteostasis Therapeutics, Inc. | Compounds, compositions and methods of increasing cftr actvity |
AU2015229188A1 (en) | 2014-03-13 | 2016-09-29 | Proteostasis Therapeutics, Inc. | Compounds, compositions, and methods for increasing CFTR activity |
WO2015196071A1 (en) | 2014-06-19 | 2015-12-23 | Proteostasis Therapeutics, Inc. | Compounds, compositions and methods of increasing cftr activity |
CA2971850A1 (en) | 2014-12-23 | 2016-06-30 | Proteostasis Therapeutics, Inc. | Derivatives of 5-phenyl- or 5-heteroarylthiazol-2-carboxylic amide useful for the treatment of inter alia cystic fibrosis |
WO2016105484A1 (en) | 2014-12-23 | 2016-06-30 | Proteostasis Therapeutics, Inc. | Derivatives of 5-(hetero)arylpyrazol-3-carboxylic amide or 1-(hetero)aryltriazol-4-carboxylic amide useful for the treatment of inter alia cystic fibrosis |
MA41253A (fr) | 2014-12-23 | 2017-10-31 | Proteostasis Therapeutics Inc | Composés, compositions et procédés pour augmenter l'activité du cftr |
WO2016105468A1 (en) | 2014-12-23 | 2016-06-30 | Proteostasis Therapeutics, Inc. | Derivatives of 3-heteroarylisoxazol-5-carboxylic amide useful for the treatment of inter alia cystic fibrosis |
MA42488A (fr) | 2015-07-24 | 2018-05-30 | Proteostasis Therapeutics Inc | Composés, compositions et procédés pour augmenter l'activité du cftr |
KR20180093882A (ko) | 2015-10-06 | 2018-08-22 | 프로테오스타시스 테라퓨틱스, 인크. | Cftr 조절용 화합물, 조성물, 및 방법 |
CN109563047A (zh) | 2016-04-07 | 2019-04-02 | 蛋白质平衡治疗股份有限公司 | 含有硅原子的依伐卡托类似物 |
AU2017280206A1 (en) | 2016-06-21 | 2019-01-17 | Proteostasis Therapeutics, Inc. | Compounds, compositions, and methods for increasing CFTR activity |
TWI735573B (zh) * | 2016-06-21 | 2021-08-11 | 美商陶氏農業科學公司 | 生產某些經取代硫亞胺之方法 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2573733A (en) * | 1950-01-03 | 1951-11-06 | Celanese Corp | Production of anthraquinone dyestuffs |
US4085093A (en) | 1976-07-23 | 1978-04-18 | The Goodyear Tire & Rubber Company | Sulfilimines as premature vulcanization inhibitors |
FR2723370B1 (fr) * | 1994-08-02 | 1996-09-13 | Roussel Uclaf | Nouveaux derives de l'imidazole, leur procede de preparation, les nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant |
AR015104A1 (es) * | 1996-11-13 | 2001-04-18 | Dowelanco | Compuestos de n-arilsulfilimina sustituidos, utiles como catalizadores en la preparacion de compuestos de n-arilarilsulfonamida; proceso para preparar dichos compuestos y su uso para catalizar dicha preparacion. |
CA2558647C (en) * | 2004-04-08 | 2013-05-28 | Dow Agrosciences Llc | Insecticidal n-substituted sulfoximines |
TWI387585B (zh) * | 2006-09-01 | 2013-03-01 | Dow Agrosciences Llc | 殺蟲性之n-取代(雜芳基)烷基烴基硫亞胺 |
TWI383970B (zh) * | 2006-11-08 | 2013-02-01 | Dow Agrosciences Llc | 多取代的吡啶基磺醯亞胺及其作為殺蟲劑之用途 |
US7868027B2 (en) * | 2007-02-26 | 2011-01-11 | Dow Agrosciences Llc | Process for the preparation of certain substituted sulfilimines |
EP2166851B1 (en) * | 2007-07-20 | 2011-09-07 | Dow AgroSciences LLC | Increasing plant vigor |
JP5320460B2 (ja) * | 2008-05-01 | 2013-10-23 | ダウ アグロサイエンシィズ エルエルシー | 相乗的殺虫混合物 |
WO2011023677A1 (en) * | 2009-08-26 | 2011-03-03 | Novartis Ag | Tetra-substituted heteroaryl compounds and their use as mdm2 and/or mdm4 modulators |
AU2013359564A1 (en) * | 2012-12-11 | 2015-06-11 | Dow Agrosciences Llc | Improved process for the preparation of|N-cyano-S-[1 -(pyridin-3-yl)ethyl]-S-methylsulfilimines |
-
2013
- 2013-02-15 UA UAA201410166A patent/UA116628C2/uk unknown
- 2013-02-15 WO PCT/US2013/026377 patent/WO2013123349A1/en active Application Filing
- 2013-02-15 AR ARP130100489A patent/AR090076A1/es active IP Right Grant
- 2013-02-15 CA CA2863994A patent/CA2863994C/en active Active
- 2013-02-15 US US13/768,543 patent/US9227936B2/en active Active
- 2013-02-15 KR KR1020147025686A patent/KR102064827B1/ko active IP Right Grant
- 2013-02-15 MX MX2014009922A patent/MX368125B/es active IP Right Grant
- 2013-02-15 EP EP13748778.1A patent/EP2814812B1/en active Active
- 2013-02-15 AU AU2013221420A patent/AU2013221420B2/en active Active
- 2013-02-15 BR BR102013003576A patent/BR102013003576B8/pt active IP Right Grant
- 2013-02-15 RU RU2014137257A patent/RU2634718C2/ru active
- 2013-02-15 JP JP2014557818A patent/JP6138834B2/ja active Active
- 2013-02-15 ES ES13748778.1T patent/ES2625106T3/es active Active
- 2013-02-15 CN CN201380019956.XA patent/CN104271555B/zh active Active
- 2013-02-15 PL PL13748778T patent/PL2814812T3/pl unknown
-
2014
- 2014-08-05 IL IL233956A patent/IL233956B/en active IP Right Grant
- 2014-09-04 ZA ZA2014/06494A patent/ZA201406494B/en unknown
- 2014-09-04 IN IN7442DEN2014 patent/IN2014DN07442A/en unknown
- 2014-09-15 CO CO14203659A patent/CO7081159A2/es unknown
-
2015
- 2015-10-29 US US14/926,874 patent/US9884824B2/en active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX368125B (es) | Metodos para producir compuestos sulfilimina. | |
PH12016500676A1 (en) | Pyrimidine fgfr4 inhibitors | |
MX2012005358A (es) | Procedimiento para la preparacion de etexilato de dabigatran. | |
MY163341A (en) | Carbohydrate based binder system and method of its production | |
UA118666C2 (uk) | Похідні піразолу | |
MX341456B (es) | Amino-quinolinas como inhibidores de cinasa. | |
MX2020002544A (es) | Sales de glicopirrolato. | |
EP2566477A4 (en) | AMINO-QUINOLINES AS KINASE INHIBITORS | |
EA201270280A1 (ru) | Соединения пиримидина в качестве ингибиторов при лечении туберкулеза | |
UA116239C2 (uk) | Нові похідні піридину | |
PH12015500345A1 (en) | Amino-quinolines as kinase inhibitors | |
MX2012008141A (es) | Compuestos y metodos. | |
CA2905610C (en) | Hyaluronic acid derivatives | |
NZ607149A (en) | Galacto-oligosaccharide-containing composition and a method of producing it | |
UA115357C2 (uk) | Похідні піридин-4-ілу | |
MX362689B (es) | Procedimiento de preparacion de derivados de acido 3,5-bis(fluoroalquil)pirazol-4-carboxilico y 3,5-bis(fluoroalquil) pirazoles. | |
MX349373B (es) | Nuevos derivados de pirazina. | |
NZ593787A (en) | Lyophilised dabigatran | |
MX2015016332A (es) | Inhibidores de alk biciclicos fusionados. | |
MX2010005015A (es) | Metodos para preparar capecitabina y un compuesto de carbonato trialquilo rico en beta-anomero. | |
WO2014141294A3 (en) | An improved process for the synthesis of melphalan and the hydrochloride salt | |
MX363458B (es) | Nuevos derivados de tetrazolona. | |
MX2016006807A (es) | Derivados de imidazol. | |
IN2014DE01203A (es) | ||
MX2015007372A (es) | Proceso mejorado para la preparacion de [n-ciano-s-[1-(piridin-3-i l) etil]-s-metilsulfiliminas. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |